.jpg)
- Two additions to the FTSE China A50 Index
- Two additions to the FTSE China 50 Index
FTSE Russell, a leading global index provider, has today announced the results of the FTSE China Index Series quarterly review for March 2023.
In the FTSE China A50 Index, Aier Eye Hospital Group (A) (SC SZ) and People's Insurance Group of China (A) (SC SH) will be added in this review period, with COSCO Shipping Holdings (A) (SC SH) and EVE Energy (A) (SC SZ) being deleted.
In the FTSE China 50 Index, China Tourism Group Duty Free (H) and Li Auto (P Chip) will be added in this review period, with China Longyuan Power Group (H) and Yankuang Energy Group (H) being deleted.
FTSE China indices are widely regarded as a leading measure of the China equities market by domestic and international investors. Nearly 60% of Assets under Management (AuM) in globally issued China Exchange Traded Funds (ETFs) track a FTSE China index.
The FTSE China A50 Index represents the 50 largest A-Share companies in China and is tracked by both domestic investors and internationally through a range of QFII/Stock Connect investment portfolios.
The FTSE China 50 Index is a tradable index which captures the largest and most liquid Chinese stocks (H Shares, P Chips and Red Chips) listed on the Hong Kong Stock Exchange.
Several changes were also made to other indices in the comprehensive FTSE China Index Series which consists of over 260 indices covering A Shares, B Shares, H Shares, Red Chips and P Chips. Full details of all inclusions and exclusions for the FTSE China Index Series can be obtained here.
All changes from this review will be made effective from start of trading on 20 March 2023. The next review will take place in June 2023.
More information about the FTSE China Index Series including index rules governing the series is available at https://www.ftserussell.com/products/indices/china
